Candriam Equities L Oncology Fund Class I Fonds
2.415,84
USD
-29,04
USD
-1,19
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 7,06% |
| AstraZeneca PLC | GB0009895292 | 5,17% |
| Merck & Co Inc | US58933Y1055 | 4,56% |
| Gilead Sciences Inc | US3755581036 | 4,40% |
| Roche Holding AG | CH0012032048 | 4,25% |
| Thermo Fisher Scientific Inc | US8835561023 | 4,20% |
| Novartis AG Registered Shares | CH0012005267 | 3,65% |
| Novo Nordisk AS Class B | DK0062498333 | 3,50% |
| Amgen Inc | US0311621009 | 3,23% |
| Intuitive Surgical Inc | US46120E6023 | 2,97% |
| Sonstige | 57,01% |